These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23611514)

  • 41. Hepatic differentiation of pluripotent stem cells.
    Loya K; Eggenschwiler R; Ko K; Sgodda M; André F; Bleidissel M; Schöler HR; Cantz T
    Biol Chem; 2009 Oct; 390(10):1047-55. PubMed ID: 19642877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.
    Slukvin II
    FEBS Lett; 2016 Nov; 590(22):4126-4143. PubMed ID: 27391301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular research using human pluripotent stem cells and humoral factors.
    Sone M; Nakao K
    Endocr J; 2013; 60(4):397-402. PubMed ID: 23363929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human pluripotent stem cells in drug discovery and predictive toxicology.
    Laustriat D; Gide J; Peschanski M
    Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges in deriving and utilizing stem cell-derived endothelial cells for regenerative medicine: a key issue in clinical therapeutic applications.
    Jalil RA; Neng LC; Kofidis T
    J Stem Cells; 2011; 6(2):93-9. PubMed ID: 22997849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Derivation and application of pluripotent stem cells for regenerative medicine.
    Wang J; Zhou Q
    Sci China Life Sci; 2016 Jun; 59(6):576-83. PubMed ID: 27225262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells.
    Lu M; Kardel MD; O'Connor MD; Eaves CJ
    Exp Hematol; 2009 Aug; 37(8):924-36. PubMed ID: 19481135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.
    Chen T; Wang F; Wu M; Wang ZZ
    J Cell Biochem; 2015 Jul; 116(7):1179-89. PubMed ID: 25740540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells.
    Seifinejad A; Taei A; Totonchi M; Vazirinasab H; Hassani SN; Aghdami N; Shahbazi E; Yazdi RS; Salekdeh GH; Baharvand H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):329-34. PubMed ID: 19912985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro.
    Klump H; Teichweyde N; Meyer C; Horn PA
    Curr Mol Med; 2013 Jun; 13(5):815-20. PubMed ID: 23642062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lost in translation: pluripotent stem cell-derived hematopoiesis.
    Ackermann M; Liebhaber S; Klusmann JH; Lachmann N
    EMBO Mol Med; 2015 Nov; 7(11):1388-402. PubMed ID: 26174486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.
    Kaufman DS
    Blood; 2009 Oct; 114(17):3513-23. PubMed ID: 19652198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.
    Paes BCMF; Moço PD; Pereira CG; Porto GS; de Sousa Russo EM; Reis LCJ; Covas DT; Picanço-Castro V
    Cell Biol Toxicol; 2017 Jun; 33(3):233-250. PubMed ID: 28039590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of pluripotent stem cells via protein transduction.
    Li X; Zhang P; Wei C; Zhang Y
    Int J Dev Biol; 2014; 58(1):21-7. PubMed ID: 24860991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential Clinical Applications of Stem Cells in Regenerative Medicine.
    Suman S; Domingues A; Ratajczak J; Ratajczak MZ
    Adv Exp Med Biol; 2019; 1201():1-22. PubMed ID: 31898779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
    Oguro H
    Methods Mol Biol; 2019; 2048():245-257. PubMed ID: 31396942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance and application of vascular niche in the development and maintenance of hematopoietic stem cells.
    Sugimura R
    Int J Hematol; 2018 Jun; 107(6):642-645. PubMed ID: 29603068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.
    Giani FC; Fiorini C; Wakabayashi A; Ludwig LS; Salem RM; Jobaliya CD; Regan SN; Ulirsch JC; Liang G; Steinberg-Shemer O; Guo MH; Esko T; Tong W; Brugnara C; Hirschhorn JN; Weiss MJ; Zon LI; Chou ST; French DL; Musunuru K; Sankaran VG
    Cell Stem Cell; 2016 Jan; 18(1):73-78. PubMed ID: 26607381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.